Background/Aims: Needle-track seeding is a rare but important complication of diagnostic and therapeutic ultrasound (US)-guided procedures in hepatocellular carcinoma (HCC). We examined the frequency of needle-track seeding after US-guided percutaneous ethanol injection (PEI), fine-needle aspiration biopsy (FNAB), and percutaneous transhepatic biliary drainage (PTBD) in order to determine the appropriate treatment for needle-track seeding and its clinical outcome. Methods: We analyzed the clinical characteristics and treatment outcomes in eight patients who experienced needle-track seeding from HCC after an US-guided procedure (FNAB, PEI, or PTBD) between January 1990 and July 2004. Results: Seven (0.14%) of 5,092 patients who experienced needle-track seeding (2 after PEI, 4 after FNAB, and 1 after PTBD) during the study period and 1 other patient who experienced needle-track seeding recently were recruited for this study. Two of the eight patients underwent mass excision and the other six patients underwent en-bloc wide excision for the needle-track seeding. Tumors recurred in the needletracks in both patients who underwent mass excision but not in the six patients who underwent en-bloc wide excision. Mortality occurred in three patients who experienced the recurrence and progression of intrahepatic HCC. Conclusions: The incidence of needle-track seeding after US-guided procedures in HCC was 0.14%. En-bloc wide excision seems to be the optimal treatment for minimizing the probability of tumor recurrence due to needle-track seeding. (Korean J Hepatol 2011;17:106-112)
INTRODUCTION

Hepatocellular carcinoma (HCC) is a common malignancy
in Asia, where chronic hepatitis B and C infections are endemic. Furthermore, HCC constitutes more than 5% of all cancers and is the dominant cause of death in patients with compensated cirrhosis, 1,2 and its incidence is increasing globally, especially in the West. 3 Ultrasound (US)-guided procedures are useful and versatile tools for the diagnosis and treatment of HCC, and have become increasingly popular since the late 1980s. 4 USguided fine-needle aspiration biopsy (FNAB) is a widely accepted and minimally invasive technique for the cytological or histological diagnosis of HCC and is considered a safe and accurate method. 4, 5 Percutaneous ethanol injection (PEI) is a safe and effective treatment modality in small HCC. 6 Percutaneous transhepatic biliary drainage (PTBD) is a useful procedure required in case of the obstructive jaundice due to bile duct invasion by HCC. 7 Although many complications have been reported to be associated with these procedures, the majority can be treated conservatively, with the notable exception of needle-track seeding. 8 However,
needle-track seeding is rare after PEI or FNAB; reported incidences range from 0.65 to 2.2% 9,10 and from 1.5 to 5.8%, 11 respectively. It has not been previously reported after PTBD (although tumor cell seeding has been reported along a catheter track in a patient with cholangiocarcinoma 12 ).
Because of the rare incidence of needle-track seeding in HCC, the treatment options and prognosis of the needle-track seeding have not been properly addressed.
We performed this study to examine the frequency of needle-track seeding after US-guided procedures such as PEI, FNAB, and PTBD in HCC, and to determine the appropriate treatment for the needle-track seeding. In addition, we investigated the clinical courses in patients with the needle-track seeding from HCC.
PATIENTS AND METHODS
Patients
We retrospectively analyzed the computerized medical records of 5,092 patients who underwent PEI (1,549 patients), FNAB (3,391 patients), or PTBD (152 patients) for HCC between January 1990 and July 2004 at Seoul National University Hospital. The study protocol was reviewed and approved by Institutional Review Board of Seoul National University Hospital.
Ultrasound-guided technique
Under US guidance (SSD-680 ultrasound scanner, Aloka, Tokyo, Japan, equipped with 3. 
Data and image analysis
We retrospectively analyzed the medical records of patients who experienced needle-track seeding and collected the The skin was involved in four patients ( Fig. 1, 2 ). and intrahepatic recurrence were not found to be significantly associated with the recurrence of needle-track seeding.
Degree of differentiation of the primary tumor could only be analyzed for seven of the eight patients, due to a lack of information on one, but was not found to be significantly associated with recurrence.
During the study period, mortalities occurred in three patients (Table 1) . These three patients received en-bloc wide excision for needle-track seeding and did not experience the recurrence after surgical resection. However, intrahepatic HCC recurred and progressed in these three patients during the study period. The patients died due to HCC progression and hepatic failure. Among two patients who experienced the recurrence of needle-track seeding after mass excision, one patient did not experienced further recurrence of needletrack seeding after repeated surgical treatment (en-bloc wide excision) and was alive by the end of the current study.
Clinical outcome of the other patient who had combined hepatocellular-cholangiocarcinoma could not be evaluated due to follow-up loss.
DISCUSSION
In the current study, the incidence of needle-track seeding from HCC after a US-guided procedure (FNAB, PEI and PTBD) was 0.14% (7 of 5,092 patients) and the incidence of implanted nodule recurrence after surgical excision was 25% (2 of 8 patients). Two patients who had undergone only mass excision instead of en-bloc wide excision experienced the recurrence of needle-track seeding after surgical excision. One of these underwent en-bloc wide excision for the recurred implanted nodule and experienced no further recurrence of needle-track seeding during the study period.
Biliary peritonitis, intra-and extrahepatic tumor seeding, and intrahepatic hematoma are the most serious complications of PEI, FNAB, and PTBD in HCC. [13] [14] [15] [16] [17] Complications after FNAB and PEI are rare, with reported incidences of 2.4% and 0.05-0.18% and mortality rates of 0.1% and 0.006-0.031%, respectively. 14, 16, [18] [19] [20] However, the overall complication rate after PTBD is higher with an incidence of 3.4-5%. 21 In the current study, two (0.13%) of the 1,549 patients who underwent PEI, four (0.12%) of the 3,391 patients who underwent FNAB, and one (0.66%) of the 152 patients who underwent PTBD for HCC experienced needle-track seeding. Silva et al in a systematic review and meta-analysis of eight observational studies found that the incidence of needle-track seeding after FNAB varied widely from 0-5.8%.
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As compared with previous reports, rates of needle-track seeding after PEI and FNAB were slightly lower in the current study. The number of patients in the current study was much larger than the previous observational studies, which would contribute to lower incidence in the current study due to the abundant experience.
The mechanism of needle-track seeding from HCC is probably complex and several causes have been discussed. 22 In animal models, Ryd et al found that FNAB can implant 10 3 -10 5 cells along a single needle-track. 23 Tumor size and degree of histologic differentiation, number of needle passes, the difference in the number of needle passes and the obtained specimens, the thickness of liver parenchyma along needle-tracks, and needle type have all been considered factors of needle-track seeding after FNAB in HCC. [24] [25] [26] [27] [28] [29] Kim et al reported that the number of needle passes seemed to affect the frequency of needle-track seeding and suggested that the life expectancies of patients influence the frequency of needle-track seeding more significantly than the size or degree of differentiation of HCC. 26 In addition, many cases of needle-track seeding after PEI have been reported. 9 Di Stasi et al reported that tumoral seeding after PEI occurs for deeply located and small HCCs, but found no relation between seeding risk and HCC cytology. 9 No report has been issued on the recurrence of needletrack seeding and the factors associated to the recurrence in HCC. In the current study, the recurrence rate of needletrack seeding was 25% among our eight patients at a median Combined hepatocellular-cholangiocarcinoma is known to have a poorer prognosis than the ordinary HCC. 34 In the current study, the frequency of needle-track seeding in patients with combined hepatocellular-cholangiocarcinoma was 12.5%, which is much larger than that in patients with ordinary HCC. Nevertheless, we believe that en-bloc wide excision might be also useful for the treatment of needletrack seeding in this subgroup. Further studies in this subgroup will be needed to clarify this issue.
Recently, the long term survivals of HCC patients are increasing due, in no small part, to the introductions of curative local ablation and liver transplantation. The current study shows that needle-track seeding can be curatively treated by en-bloc excision without recurrence, and that therefore, it should not be considered to be similar to systemic metastasis. Therefore our findings indicate that needle-track seeding, if it is treated by en-bloc wide excision,
should not be considered as contraindication for liver transplantation.
Taken together, needle-track seeding after PEI or FNAB by HCC is a rare but important complication, and it can also occur after PTBD for biliary obstruction by HCC. However, the result of follow-up indicates that the prognosis of needle-track seeding, when it is treated by en-bloc wide excision, is favorable. Our results suggest that implanted nodules should be treated by en-bloc wide excision in cases with needle-track seeding from HCC after an US-guided procedure, especially in patients awaiting liver transplantation.
